Last reviewed · How we verify
NT-101 High Dose
At a glance
| Generic name | NT-101 High Dose |
|---|---|
| Sponsor | NexThera Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- NT-101 Topical Ophthalmic Solution in Patients With Wet AMD (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |